Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis
S. A. Murphy(Brigham and Women's Hospital), Eugene Braunwald(Mass General Brigham), Shaun G. Goodman(University of Toronto), David A. Morrow(University of California, San Francisco), Frans Van de Werf(KU Leuven), Ian Menown(Craigavon Area Hospital), Carolyn H. McCabe(Brigham and Women's Hospital), Elliot M. Antman(Brigham and Women's Hospital), Mauricio G. Cohen(Santa Ana College), C. Michael Gibson(Baim Institute for Clinical Research), Kenneth W. Mahaffey(Cardiovascular Institute of the South)
Cited by 196
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k